Refractory immune thrombocytopenia in systemic lupus erythematosus: Response to mycophenolate mofetil
10.1191/0961203303lu417cr
Saved in:
Main Authors: | Vasoo, S., Thumboo, J., Fong, K.-Y. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/117833 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Use of rituximab in the treatment of refractory systemic lupus erythematosus: Singapore experience
by: Lateef, A., et al.
Published: (2016) -
Good outcomes with mycophenolate-cyclosporine-based induction protocol in children with severe proliferative lupus nephritis
by: Aragon, E., et al.
Published: (2011) -
Danazol in the Treatment of Systemic Lupus Erythematosus: A Qualitative Systematic Review
by: Letchumanan, P., et al.
Published: (2011) -
Mycophenolate mofetil in the treatment of non-renal manifestations of systemic lupus erythematosus: A review
by: Fong, K.-Y.
Published: (2015) -
Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression
by: Mak, A., et al.
Published: (2011)